Ranbaxy Can't Ask 1st Circ. To Toss Drug Buyers' Suit
A Massachusetts federal judge refused Friday to let Ranbaxy Laboratories seek First Circuit relief from multidistrict litigation accusing the company of gaming the generic drug approval system to gain an unfair competitive...To view the full article, register now.
Already a subscriber? Click here to view full article